AuntMinnie
OCTOBER 25, 2023
Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bone scans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bone scans in calciphylaxis based on a review of the literature.
AuntMinnie
FEBRUARY 26, 2025
The new horizons of advanced imaging, especially in oncology, must increasingly consider not only diagnostic efficacy but also sustainability for patients, prize-winning researchers told ECR 2025 delegates. To mitigate these effects, low-energy imaging techniques should be prioritized without compromising diagnostic accuracy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Diagnostic Imaging
NOVEMBER 16, 2023
Fifty-seven percent of patients with prostate cancer diagnosed with osseous metastases on bone scans had negative findings on PSMA PET imaging, according to findings from an international multicenter comparative study.
AuntMinnie
JULY 1, 2024
The diagnosis and management of intermediate-risk and high-risk prostate cancer are increasingly informed by advances in diagnostic imaging, the authors noted. "F-18 PSMA-1007 PET/CT provided improved accuracy compared with multiparametric MRI for prostate cancer tumor staging before radical treatment," the group wrote.
AuntMinnie
NOVEMBER 25, 2023
ng/mL after prostatectomy or ≥ 2 ng/mL after radiotherapy) and negative conventional imaging (CT and/or bone scans). The primary endpoint was the diagnostic performance of Ga-68 RM2-PET/MRI versus MRI alone, with the imaging sets interpreted by three independent experts using a standardized evaluation criteria.
Diagnostic Imaging
OCTOBER 30, 2023
Imaging experts discuss the challenges with traditional imaging modalities for prostate cancer, commenting on the bone scan and CT scan.
Diagnostic Imaging
OCTOBER 24, 2024
percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study. For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8
Expert insights. Personalized for you.
297 
Let's personalize your content